BIG
BVS icon

Brooklyn Investment Group’s Bioventus BVS Stock Holding History

Brooklyn Investment Group’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Buy
116,219
+104,170
+865% +$874K 0.03% 527
2025
Q4 		$90.7K Buy
+12,049
New +$86.6K ﹤0.01% 1472

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Brooklyn Investment Group's BVS Position: Q1 2026 in Review

Brooklyn Investment Group increased its Bioventus (BVS) stake by 865% in Q1 2026, buying an estimated $874K and bringing the position to 116,219 shares worth $1.06M. The position accounts for 0.03% of the portfolio, ranked #527.

Brooklyn Investment Group first reported a position in BVS in Q4 2025 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Brooklyn Investment Group held 116,219 shares of Bioventus worth $1.06M as of Q1 2026.
  • Brooklyn Investment Group bought 104,170 Bioventus shares in Q1 2026, an estimated $874K.
  • Bioventus made up 0.03% of Brooklyn Investment Group's portfolio in Q1 2026, its #527 holding.
  • Brooklyn Investment Group first reported a position in Bioventus in Q4 2025 and has held it in 2 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.